Acesion Pharma Announces Positive Pre-Clinical Data for AP31969
Copenhagen, Denmark – Acesion Pharma (“Acesion” or “the Company”), a biotech company pioneering first-in-class novel therapies for atrial...
top of page
- Mar 14
- 5 min
Positive phase 2 data from Atrial Fibrillation clinical trial – primary endpoint met
First-in-class SK channel inhibition proof of mechanism achieved First new approach to treating Atrial Fibrillation for 20 years...
1,600 views
- May 5, 2020
- 2 min
Acesion Pharma Strengthens Clinical Team with Key Appointments
Acesion Pharma, a Danish pharmaceutical company developing novel treatments for atrial fibrillation (AF), the most common cardiac...
258 views
LATEST NEWS
bottom of page